Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

RLAY holding history

Relay Therapeutics, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RLAY overviewAll 13F holders of RLAYFull Q2 2026 holdings

Shares (Q2 2026)
28,197
Value
$527.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RLAY by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202628,197$527.6K<0.1%−212−0.7%ReducedHolders
Q1 202628,409$282.7K<0.1%−4,982−14.9%ReducedHolders
Q4 202533,391$282.5K<0.1%+4,615+16.0%AddedHolders
Q3 202528,776$150.2K<0.1%−4,781−14.2%ReducedHolders
Q2 202533,557$116.1K<0.1%−1,325−3.8%ReducedHolders
Q1 202534,882$91.4K<0.1%−7,318−17.3%ReducedHolders
Q4 202442,200$173.9K<0.1%+15,492+58.0%AddedHolders
Q3 202426,708$189.1K<0.1%+5,825+27.9%AddedHolders
Q2 202420,883$136.2K<0.1%−5,331−20.3%ReducedHolders
Q1 202426,214$217.6K<0.1%+3,394+14.9%AddedHolders
Q4 202322,820$251.2K<0.1%+3,107+15.8%AddedHolders
Q3 202319,713$165.8K<0.1%+102+0.5%AddedHolders
Q2 202319,611$246.3K<0.1%+1,178+6.4%AddedHolders
Q1 202318,433$303.6K<0.1%−2,517−12.0%ReducedHolders
Q4 202220,950$313.0K<0.1%+3,355+19.1%AddedHolders
Q3 202217,595$394.0K<0.1%+538+3.2%AddedHolders
Q2 202217,057$286.0K<0.1%−7,270−29.9%ReducedHolders
Q1 202224,327$728.0K<0.1%−6,173−20.2%ReducedHolders
Q4 202130,500$936.0K<0.1%+3,005+10.9%AddedHolders
Q3 202127,495$867.0K<0.1%−4,291−13.5%ReducedHolders
Q2 202131,786$1.16M<0.1%+7,080+28.7%AddedHolders
Q1 202124,706$854.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.